Related Experiment Video
Updated: Jun 18, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
Statin intolerance and the drucebo effect
B Mugawar1, S Mcerlean2, P O' Connor1,3
1Department of Pharmacology, Trinity College Dublin School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland.
Abstract:
Hypercholesterolemia is a well-described risk factor for atherosclerotic cardiovascular disease. Statins remain the cornerstone of therapy. Statin intolerance (SI) particularly statin associated muscle symptoms (SAMS) and inappropriate stopping of treatment is associated with increased cardiovascular risk. A significant proportion of reported SAMS relates to expectation of side effects and can be termed the 'negative drucebo effect'. Patients should be educated about SI, the negative drucebo effect, in addition to the benefits of adherence to the therapy when first prescribed a statin. The aim of this commentary is to discuss the issue of SI, the negative drucebo effect and to suggest some interventions that may be used to address this issue.
Related Concept Videos
The Placebo Effect
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blind Procedures
Blinding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drugs for Treatment of Constipation-Predominant IBS

